Literature DB >> 6172309

Synergistic enhancement of bleomycin cytotoxicity toward tumor cells in culture by a combination of ethanol and moderate hyperthermia.

A Ishida, S Mizuno.   

Abstract

Bleomycin cytotoxicity toward mouse mammary carcinoma FM3A cells and human carcinoma HeLa S3 cells in culture was greatly potentiated by exposing the cells to a combination of a low concentration of ethanol and moderate hyperthermia. For example, the exposure of FM3A cells to a combination of 4.3% ethanol and 39 degrees, 2.4% ethanol and 41 degrees or 1.5% ethanol and 42 degrees induced a marked sensitization which was almost equivalent to that induced by exposure to 6% ethanol at 37 degrees and was greater than that induced by exposure to 43 degrees hyperthermia alone. However, when the cells were exposed to 3% ethanol at 37 degrees and then treated with bleomycin at 41 degrees, sensitization was hardly induced, indicating a requirement for simultaneous exposure to ethanol and hyperthermia to produce a synergistic increase in bleomycin cytoxicity. A possible application of these findings to cancer treatment with bleomycin is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172309

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  3 in total

1.  Enhanced antitumor effects of bleomycin and moderate hyperthermia by additional use of ethanol.

Authors:  W Takiyama; T Hirai; Y Miyoshi; T Yoshihara; T Hattori
Journal:  Jpn J Surg       Date:  1984-05

2.  Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.

Authors:  J Mircheva; P J Smith; N M Bleehen
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

Review 3.  Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.

Authors:  Arlene L Oei; Lianne E M Vriend; Johannes Crezee; Nicolaas A P Franken; Przemek M Krawczyk
Journal:  Radiat Oncol       Date:  2015-08-07       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.